CHRW
48
8
TGT
50
2
LH
55
2
MNST
52
2
M
14
2
NRG
57
2
CRM
50
-5
ADI
56
-3
SRE
54
-5
SPG
53
-2
SYY
50
-8
MSFT
54
-3
NTAP
58
2
ADT
33
5
DVN
35
2
MSI
69
-3
DTE
56
-7
VRTX
56
-4
BWA
42
-2
NFLX
55
-3
CHRW
48
8
TGT
50
2
LH
55
2
MNST
52
2
M
14
2
NRG
57
2
CRM
50
-5
ADI
56
-3
SRE
54
-5
SPG
53
-2
SYY
50
-8
MSFT
54
-3
NTAP
58
2
ADT
33
5
DVN
35
2
MSI
69
-3
DTE
56
-7
VRTX
56
-4
BWA
42
-2
NFLX
55
-3
Financhill
Back

Theriva Biologics 10K Form

Buy
74

TOVX
Theriva Biologics

Last Price:
3.87
Seasonality Move:
-14.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOVX News And Ratings

See the #1 stock for the next 7 days that we like better than TOVX

TOVX Financial Statistics

Sales & Book Value

Annual Sales: $2.61M
Cash Flow: $-3.45M
Price / Cash Flow: 0
Annual Sales: $28.92
Price / Book: 0.15

Profitability

EPS (TTM): -31.25000
Net Income (TTM): $-22.27M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Theriva Biologics Earnings Forecast

Key Theriva Biologics Financial Ratios

  • The Selling, General & Administrative Expenses for TOVX have been equal to 80.99% of Gross Profit Margin.
  • The Interest Expense is -0.26% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 13 years.

Theriva Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TOVX
Website: therivabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOVX Technical Analysis vs Fundamental Analysis

Buy
74
Theriva Biologics (TOVX) is a Buy

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Buy
    The current Theriva Biologics [TOVX] share price is $3.95. The Score for TOVX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.